Orgnization, W. H. COVID-19 epidemiological update—19 January 2024, <https://www.who.int/publications/m/item/covid-19-epidemiological-update—19-january-2024> (2014).
Rosenthal, N., Cao, Z., Gundrum, J., Sianis, J. & Safo, S. Risk factors associated with in-hospital mortality in a US National sample of patients with COVID-19. JAMA Netw. Open 3, e2029058. https://doi.org/10.1001/jamanetworkopen.2020.29058 (2020).
Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet (London, England) 395, 1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3 (2020).
Ambrosioni, J. et al. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV 8, e294–e305. https://doi.org/10.1016/s2352-3018(21)00070-9 (2021).
Fung, M. & Babik, J. M. COVID-19 in immunocompromised hosts: What we know so far. Clin. Infect. Dis. 72, 340–350. https://doi.org/10.1093/cid/ciaa863 (2021).
Zsichla, L. & Müller, V. Risk factors of severe COVID-19: A review of host, viral and environmental factors. Viruses 15, 175. https://doi.org/10.3390/v15010175 (2023).
Martono, A., Fatmawati, F. & Mulyanti, S. Risk factors associated with the severity of COVID-19. Malays. J. Med. Sci. MJMS 30, 84–92. https://doi.org/10.21315/mjms2023.30.3.7 (2023).
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa. Clin. Infect. Dis. 73, e2005–e2015. https://doi.org/10.1093/cid/ciaa1198 (2021).
Bhaskaran, K. et al. HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV 8, e24–e32. https://doi.org/10.1016/s2352-3018(20)30305-2 (2021).
Geretti, A. M. et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study. Clin. Infect. Dis. 73, e2095–e2106. https://doi.org/10.1093/cid/ciaa1605 (2021).
Chun, H. M. et al. A systematic review of COVID-19 vaccine antibody responses in people with HIV. Open Forum Infect. Dis. 9, ofac579. https://doi.org/10.1093/ofid/ofac579 (2022).
Haidar, G. et al. Prospective evaluation of coronavirus disease 2019 (COVID-19) vaccine responses across a broad spectrum of immunocompromising conditions: The COVID-19 vaccination in the immunocompromised study (COVICS). Clin. Infect. Dis. 75, e630–e644. https://doi.org/10.1093/cid/ciac103 (2022).
Opsteen, S. et al. Impact of chronic HIV infection on acute immune responses to SARS-CoV-2. J. Acquir. Immune Defic. Syndr. 1999(96), 92–100. https://doi.org/10.1097/qai.0000000000003399 (2024).
Dandachi, D. et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin. Infect. Dis. 73, e1964–e1972. https://doi.org/10.1093/cid/ciaa1339 (2021).
Hoffmann, C. et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 22, 372–378. https://doi.org/10.1111/hiv.13037 (2021).
Tesoriero, J. M. et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw. Open 4, e2037069. https://doi.org/10.1001/jamanetworkopen.2020.37069 (2021).
Sun, J. et al. COVID-19 disease severity among people with HIV infection or solid organ transplant in the United States: A nationally-representative, multicenter, observational cohort study. medRxiv. https://doi.org/10.1101/2021.07.26.21261028 (2021).
Cheng, W. et al. SARS-CoV-2 infection, hospitalization, and associated factors among people living with HIV in Southeastern China from December 2022 to February 2023: Cross-Sectional Survey. JMIR Public Health Surveill. 10, e51449. https://doi.org/10.2196/51449 (2024).
Gervasoni, C. et al. Clinical features and outcomes of patients with human immunodeficiency virus with COVID-19. Clin. Infect. Dis. 71, 2276–2278. https://doi.org/10.1093/cid/ciaa579 (2020).
Härter, G. et al. COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients. Infection 48, 681–686. https://doi.org/10.1007/s15010-020-01438-z (2020).
Karmen-Tuohy, S. et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J. Acquir. Immune Defic. Syndr. 1999(85), 6–10. https://doi.org/10.1097/qai.0000000000002423 (2020).
Patel, V. V. et al. Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. J. Acquir. Immune Defic. Syndr. 1999(86), 224–230. https://doi.org/10.1097/qai.0000000000002578 (2021).
Shalev, N. et al. Clinical characteristics and outcomes in people living with human immunodeficiency virus hospitalized for coronavirus disease 2019. Clin. Infect. Dis. 71, 2294–2297. https://doi.org/10.1093/cid/ciaa635 (2020).
Sigel, K. et al. Coronavirus 2019 and people living with human immunodeficiency virus: Outcomes for hospitalized patients in New York City. Clin. Infect. Dis. 71, 2933–2938. https://doi.org/10.1093/cid/ciaa880 (2020).
Stoeckle, K. et al. COVID-19 in hospitalized adults with HIV. Open Forum Infect. Dis. 7, ofaa327. https://doi.org/10.1093/ofid/ofaa327 (2020).
Vizcarra, P. et al. Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort. Lancet HIV 7, e554–e564. https://doi.org/10.1016/s2352-3018(20)30164-8 (2020).
Mascolo, S., Romanelli, A., Carleo, M. A. & Esposito, V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J. Med. Virol. 92, 1777–1778. https://doi.org/10.1002/jmv.25881 (2020).
Laurence, J. Why aren’t people living with HIV at higher risk for developing severe coronavirus disease 2019 (COVID-19)?. AIDS Patient Care STDS 34, 247–248. https://doi.org/10.1089/apc.2020.29005.com (2020).
Del Amo, J. et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: A cohort study. Ann. Intern. Med. 173, 536–541. https://doi.org/10.7326/m20-3689 (2020).
Samantaray, N. N., Kar, N. & Mishra, S. R. A follow-up study on treatment effects of cognitive-behavioral therapy on social anxiety disorder: Impact of COVID-19 fear during post-lockdown period. Psychiatry Res. 310, 114439. https://doi.org/10.1016/j.psychres.2022.114439 (2022).
Czorniej, K. P., Krajewska-Kulak, E. & Kulak, W. Assessment of anxiety disorders in students starting work with coronavirus patients during a pandemic in Podlaskie Province, Poland. Front. Psychiatry 13, 980361. https://doi.org/10.3389/fpsyt.2022.980361 (2022).
Hoffart, A., Johnson, S. U. & Ebrahimi, O. V. The network of stress-related states and depression and anxiety symptoms during the COVID-19 lockdown. J. Affect. Disord. 294, 671–678. https://doi.org/10.1016/j.jad.2021.07.019 (2021).
Khosravani, V., Asmundson, G. J. G., Taylor, S., Bastan, F. S. & Ardestani, S. M. S. The Persian COVID stress scales (Persian-CSS) and COVID-19-related stress reactions in patients with obsessive-compulsive and anxiety disorders. J. Obsessive-Compulsive Related Disord. 28, 100615. https://doi.org/10.1016/j.jocrd.2020.100615 (2021).
Duko, B., Toma, A., Asnake, S. & Abraham, Y. Depression, anxiety and their correlates among patients with HIV in South Ethiopia: An institution-based cross-sectional study. Front. Psychiatry 10, 290. https://doi.org/10.3389/fpsyt.2019.00290 (2019).
Nakasujja, N. et al. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry 10, 44. https://doi.org/10.1186/1471-244x-10-44 (2010).
Jin, C., Zhao, G., Zhang, F., Feng, L. & Wu, N. The psychological status of HIV-positive people and their psychosocial experiences in eastern China. HIV Med. 11, 253–259. https://doi.org/10.1111/j.1468-1293.2009.00770.x (2010).
Argyropoulos, S. V. et al. Development and validation of the Generalized Anxiety Disorder Inventory (GADI). J. Psychopharmacol. 21, 145–152. https://doi.org/10.1177/0269881107069944 (2007).
Naragon-Gainey, K., Gallagher, M. W. & Brown, T. A. A longitudinal examination of psychosocial impairment across the anxiety disorders. Psychol. Med. 44, 1691–1700. https://doi.org/10.1017/s0033291713001967 (2014).
Qi, T. et al. COVID-19 pandemic related long-term chronic stress on the prevalence of depression and anxiety in the general population. BMC Psychiatry 21, 380. https://doi.org/10.1186/s12888-021-03385-x (2021).
Zeynalova, N. et al. The association between an anxiety disorder and cancer in medical history. J. Affect. Disord. 246, 640–642. https://doi.org/10.1016/j.jad.2018.12.019 (2019).
Buysse, D. J., Reynolds, C. F. 3rd., Monk, T. H., Berman, S. R. & Kupfer, D. J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 28, 193–213. https://doi.org/10.1016/0165-1781(89)90047-4 (1989).
Spitzer, R. L., Kroenke, K., Williams, J. B. & Löwe, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 166, 1092–1097. https://doi.org/10.1001/archinte.166.10.1092 (2006).
Sacks, D. et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int. J. Stroke 13, 612–632. https://doi.org/10.1177/1747493018778713 (2018).
Tong, X., An, D., McGonigal, A., Park, S. P. & Zhou, D. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 120, 31–36. https://doi.org/10.1016/j.eplepsyres.2015.11.019 (2016).
Mirzaei, H., McFarland, W., Karamouzian, M. & Sharifi, H. COVID-19 among people living with HIV: A systematic review. AIDS Behav. 25, 85–92. https://doi.org/10.1007/s10461-020-02983-2 (2021).
Danwang, C., Noubiap, J. J., Robert, A. & Yombi, J. C. Outcomes of patients with HIV and COVID-19 co-infection: A systematic review and meta-analysis. AIDS Res. Ther. 19, 3. https://doi.org/10.1186/s12981-021-00427-y (2022).
Yang, X. et al. Associations between HIV infection and clinical spectrum of COVID-19: A population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV 8, e690–e700. https://doi.org/10.1016/s2352-3018(21)00239-3 (2021).
Nomah, D. K. et al. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: A retrospective cohort study. Lancet HIV 8, e701–e710. https://doi.org/10.1016/s2352-3018(21)00240-x (2021).
Del Amo, J., Polo, R., Moreno, S., Jarrín, I. & Hernán, M. A. SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment. AIDS (London, England) 36, 161–168. https://doi.org/10.1097/qad.0000000000003132 (2022).
Ssentongo, P. et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis. Sci. Rep. 11, 6283. https://doi.org/10.1038/s41598-021-85359-3 (2021).
Hedberg, P. et al. Incidence and severity of COVID-19 in adults with and without HIV diagnosis. J. Intern. Med. 292, 168–171. https://doi.org/10.1111/joim.13481 (2022).
Khan, K. et al. Immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with human immunodeficiency virus (HIV). Clin. Infect. Dis. 75, e857–e864. https://doi.org/10.1093/cid/ciab1008 (2022).
Glover, N. A. et al. Lung outcomes and related risk factors in patients after SARS-CoV-2 infection: A hospitalised single-centre cohort from Johannesburg, South Africa. EClinicalMedicine 71, 102588. https://doi.org/10.1016/j.eclinm.2024.102588 (2024).
Bachelard, A. et al. Risk factors associated with severe/critical COVID-19 in people living with HIV-1. Int. J. Infect. Dis. 122, 152–154. https://doi.org/10.1016/j.ijid.2022.05.055 (2022).
Moreno-Torres, V. et al. Predictors of in-hospital mortality in HIV-infected patients with COVID-19. QJM Mon. J. Assoc. Physicians 116, 57–62. https://doi.org/10.1093/qjmed/hcac215 (2023).
Eisinger, R. W., Lerner, A. M. & Fauci, A. S. Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics. J. Infect. Dis. 224, 1455–1461. https://doi.org/10.1093/infdis/jiab114 (2021).
Cooper, T. J., Woodward, B. L., Alom, S. & Harky, A. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: A systematic review. HIV Med. 21, 567–577. https://doi.org/10.1111/hiv.12911 (2020).
Costenaro, P., Minotti, C., Barbieri, E., Giaquinto, C. & Donà, D. SARS-CoV-2 infection in people living with HIV: A systematic review. Rev. Med. Virol. 31, 1–12. https://doi.org/10.1002/rmv.2155 (2021).
Jagielski, P. et al. Associations of nutritional behavior and gut microbiota with the risk of COVID-19 in healthy young adults in Poland. Nutrients 14, 350. https://doi.org/10.3390/nu14020350 (2022).
Lovik, A. et al. Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients—An observational study of five cohorts across four countries. Lancet Reg. Health Europe 33, 100733. https://doi.org/10.1016/j.lanepe.2023.100733 (2023).
Wang, C. et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int. J. Environ. Res. Public Health 17, 1729. https://doi.org/10.3390/ijerph17051729 (2020).
Liu, Y. et al. Using mindfulness to reduce anxiety and depression of patients with fever undergoing screening in an isolation ward during the COVID-19 outbreak. Front. Psychol. 12, 664964. https://doi.org/10.3389/fpsyg.2021.664964 (2021).
O’Donovan, A. et al. Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion-biology relationships. Brain Behav. Immun. 24, 1074–1077. https://doi.org/10.1016/j.bbi.2010.03.003 (2010).
Rammal, H., Bouayed, J., Falla, J., Boujedaini, N. & Soulimani, R. The impact of high anxiety level on cellular and humoral immunity in mice. NeuroImmunoModulation 17, 1–8. https://doi.org/10.1159/000243079 (2010).
Vida, C., González, E. M. & De la Fuente, M. Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety. Curr. Pharm. Des. 20, 4656–4678. https://doi.org/10.2174/1381612820666140130201734 (2014).
Pérez-Barragán, E. et al. COVID-19 in people living with HIV: A single-center descriptive study. J. Infect. Dev. Ctries 16, 1796–1799. https://doi.org/10.3855/jidc.16990 (2022).